---
layout: page
title: Microfluidic Concentration Gradient Chip for Drug Susceptibility
description: Device engineering for microbial testing
img: assets/img/microfluidics.jpg
importance: 9
category: wearable-sensing
---

## Overview

A research project developing a microfluidic concentration gradient chip for rapid and cost-effective gradient-based microbial drug susceptibility testing, with applications in clinical microbiology and antimicrobial resistance monitoring.

## Intellectual Property

- **1 Invention Patent**: Microfluidic device with gradient generation
- **1 Utility Model Patent**: Manufacturing and assembly optimization

## Publication

Published in *Chinese Journal of Medical Physics*, 2021.

Shi, H., Cao, Y., **Zhou, Y.**, et al. "Development and Application of Microfluidic Concentration Gradient Chip"

## Funding

**PhD Research Startup Fund**: EA202008205

## Clinical Significance

Traditional microbial drug susceptibility testing faces challenges:
- **Time-consuming**: 24-72 hour culture requirement
- **Resource intensive**: Large sample volumes needed
- **Labor demanding**: Manual preparation and interpretation
- **Reproducibility issues**: Concentration gradient variability

## Key Innovations

### Device Design
- **Gradient Generation**: Passive mixing via diffusion and hydrodynamic focusing
- **Concentration Range**: 8-point logarithmic gradient (1-1000 µM)
- **Precision**: ±5% concentration uniformity across gradient
- **Integration**: Multiple testing zones on single chip

### Microfluidic Principles
- **Laminar Flow**: Reynolds number control for stable gradients
- **Channel Design**: Optimized geometry for rapid equilibration
- **Valve Integration**: On-chip sample loading and routing
- **Biocompatibility**: PDMS substrate with surface coatings

## Experimental Validation

### Performance Metrics
- **Concentration Linearity**: R² > 0.98
- **Temporal Stability**: <2% drift over 4 hours
- **Spatial Uniformity**: ±3% across transverse direction
- **Reproducibility**: Inter-chip CV < 5%

### Microbial Testing
- **Organism Coverage**: *E. coli*, *S. aureus*, *P. aeruginosa*
- **Drug Panels**: Aminoglycosides, fluoroquinolones, β-lactams
- **MIC Accuracy**: ±1 dilution of reference (EUCAST)
- **Time Reduction**: 6-8 hours vs. 24-72 hours traditional

## Clinical Applications

- **Antibiotic Stewardship**: Rapid resistance detection
- **Point-of-Care Testing**: Decentralized susceptibility assessment
- **Infection Control**: Quick turnaround for severe infections
- **Epidemiology**: Large-scale resistance surveillance

## Manufacturing

- **Fabrication Method**: Soft lithography with PDMS molding
- **Scale-Up**: Compatible with mass production
- **Cost**: <$5 per chip vs. >$20 for traditional methods
- **Shelf Life**: 12+ months at 4°C

## Collaborators

**A/Prof. Shi Huanhuan** - Associate Professor, Department of Biomedical Engineering

## Future Directions

- Multi-pathogen detection panels
- Integration with smartphone microscopy
- Real-time growth kinetics monitoring
- AI-assisted result interpretation

## Links

- **Publication**: [Chinese Journal of Medical Physics, 2021](https://doi.org/xxxx)
- **Patent Database**: Chinese Patent Office
- **GitHub**: [arnold117](https://github.com/arnold117)

## Timeline

- **Start**: December 2019
- **End**: December 2021
- **Duration**: 24 months
- **Publication**: 2021
